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ABSTRACT
The objective of this thesis project is to assess inflammatory leukocyte presence
and accumulation in vascular atherosclerotic plaque using [111In] In-DANBIRT as
a non-invasive diagnostic imaging tool. ApoE-/-mice were fed either normal or
high fat diet (HFD) for 8 weeks. Sprague Dawley male rats were exposed to
filtered air and ozone for 4 hours. SPECT/CT imaging was performed at baseline,
4 and 8 weeks. 3D autoradiography was performed after 8 weeks. Leukocyte
isolation methods were performed for neutrophil and peripheral blood
mononuclear cell (PBMC) separations post-incubation with [68Ga] Ga-DANBIRT
and [111In] In-DANBIRT. Whole blood isolation correlated these findings showing
increased specific uptake by neutrophils in the ozone-exposed group.
Radioisotopic dilution methods evidence a saturation of binding sites in isolated
neutrophil samples starting at a 10-fold dilution from initial concentration of [111In]
In-DANBIRT. Longitudinal molecular imaging evidenced an increased uptake in
HFD fed mice, consistent with increased immune response to vascular injury in
cardiovascular and immune tissues. Histologic analysis illustrated atherosclerotic
plaque disease progression and increased vascular lesion area in HFD fed mice.
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PREFACE
I will start by pointing out that my path in cardiovascular research started
by a determining personal moment when I lost a very close and loved uncle due
to atherosclerotic disease complications. As a physician there was a direct sense
of personal blame due to not being able to be there to save his life. I became
immediately drawn into this thesis project because of the implication of having a
transcendental impact in modern medicine. The implications of this thesis project
have a real value as translational research and could lead the way in a major
breakthrough in molecular imaging.
Evolution has made it very clear that in order to survive we have to adapt
and enhance our survival ability. In the context of health, we as humans have to
rely in biotechnological advance to extend the chance of survival. Because
disease pathogenesis varies exponentially in every patient, the effort of modern
medicine is to improve continuously. Many of the capabilities for understanding
pathogenesis impact the ability to prevent and diagnose disease as early as
possible. In some cases this is achievable, but in many others the course of a
disease is dictated by fatal outcomes. With great power comes great
responsibility and in molecular imaging the power of such diagnostic systems are
limited by patient’s safety. There are many comprehensive approaches to identify
areas that are prone to atherosclerotic plaque rupture and subsequent
complications.
The rationale relies on the vulnerable stage of atheroma development in
which such intense immune response can be identified using molecular imaging.
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The specific aim is to validate the capability of [111In] In-DANBIRT as an in vivo
imaging tool for atherosclerosis’ inflammatory progression in the developmental
stages of plaque instability.
I have hypothesized that using a Single Photon Emission Computerized
Tomography (SPECT) imaging system I am able to discriminate [111In] InDANBIRT uptake in areas prone to vascular atherosclerosis development. As of
today, there are no reliable noninvasive in vivo imaging tools for such purpose,
taking the importance of findings to a next level.
Extent of hypothesized results impact beyond the scope of this project and apply
to multiple disease models such as infection, inflammation, cancer (leukemia,
lymphoma and other hematopoietic diseases) and most diseases affected by an
immune modulation. Drug delivery systems and imaging diagnostic technology
are required to be able to translate preclinical medical advantages.
There is a stronger commitment in modern medicine to discover new
technology rather than to find better uses of available biotechnological resources.
Restructuring and repurposing(Oprea, Bauman, Bologa, Buranda et al., 2011)
are terms that are overlooked and limited as secondary efforts most of the time.
The most important asset of nuclear medicine and molecular imaging is the
ability to investigate a system without the system knowing. Having such ability
has many aspects to the argument but there is great potential for obtaining high
specificity using such modalities. Metabolic pathways and physiological
processes can become altered by working in such low pharmacologic levels,
relying on high affinity binding to the target molecule. The interaction of
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radioactivity using high performance imaging systems has been implemented
since ancient times were it was seen as a complicated method rather than an
indispensible diagnostic tool. Even today, most nuclear medicine procedures are
remained as last resources and believed to have limited potential as gold
standards. Believing that there is an increased potential in the chemical
restructure and rescuing of [111In] In-DANBIRT guided me to pursue this thesis
project with the firm conviction it is a promising molecular imaging probe.
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Chapter 1. Introduction
Cardiovascular disease and atherosclerosis epidemiology
Cardiovascular disease is among the leading causes of death in the
modern world(Coste, 2001); around 70% of cardiovascular complications are
related to atherosclerosis, especially in small vessels(Herrington, Lacey,
Sherliker, Armitage et al., 2016; Naruko, Ueda, Haze, van der Wal et al., 2002).
Coronary arteries are the most frequently affected vessels and cause the worst
outcomes(Abedinzadeh, Pedram, Sadeghian, Nodushan et al., 2015). Although
the number of coronary atherosclerosis-related emergency room visits have
decreased from 2006 to 2011 in the US(Skinner, Blanchard, & Elixhauser, 2006),
there is still a substantial number of patients that develop complications directly
related to an atherosclerotic vascular condition.
Statistics from NHLBI highlight that in 2010 cardiovascular disease caused
788,000 deaths or 32% of all deaths in the US. Such numbers reflect a global
pandemic scenario, considering that such numbers are close to or higher in lowincome countries like Mexico(Rodriguez-Saldana, Rodriguez-Flores, Cantu-Brito,
& Aguirre-Garcia, 2014). As such, preventive therapies should be a major priority
in biomedical research(Herrington, Lacey, Sherliker, Armitage et al., 2016).
Knowing that cardiovascular risks vary between each individual, the relationship
from one person to its environment is without a doubt an important evolutionary
phenomenon till this day.
Most of the clinical implications of atherosclerosis development depend in
the affected vessel, as mentioned. Arterial vessels like the carotids, supply most
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of the blood flow to the brain, neck and adjacent structures to the heart. Such
vital functions are affected by atherosclerosis by remodeling the vessel wall
lumen, thereby reducing blood flow or increasing shear turbulence. Serious
complications like stroke, heart attacks and unstable angina arise from such
etiologies and can be life-threatening.
Risks for developing cardiovascular disease are related to lifestyle,
genetic predisposition, environmental exposure, modifiable and non-modifiable
risk factors. Risk factors are important to guide diagnosis, while improving
therapeutics based on risk stratification, improving true value of risk prediction.
Most diagnostic tools are able to identify atherosclerosis-associated incidental
findings like aortic curvature calcification in X-Rays and Computerized
Tomography, hypercholesterolemia in screening blood test and physical
evaluation that can reveal signs and symptoms of decreased blood flow in certain
anatomical regions. Every human being responds differently, the importance in
this statement is that while modern medicine agrees that there are compelling
risk factors for cardiovascular disease, many others remain to be stratified and
can represent a challenge to diagnose in a timely manner.
Atherosclerosis is a chronic cardiovascular disease, adversely influenced
by increased serum lipid levels (cholesterol, triglycerides(Durrington, 1998))
especially in concentrations of small lipoprotein particles (LDL, VLDL), which can
accumulate inside the intima of injured vessels. The process is characterized as
an early stage with the pathognomonic formation of “foam cells”, which are
macrophages that release cytokines and phagocytize large amounts of
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intraplaque lipids(Brown, Shelness, & Rudel, 2007). Accumulation of these cells
has been identified in the early-stage lesion of atheroma.
An immune response proliferates from an increase in local and systemic
cytokines, increasing the amount of leukocyte recruitment that interacts with
activated endothelial cells and translocate into the vessel wall. As cellularity in
the lesion increases, partial or complete vessel lumen narrowing becomes the
single most important feature capable of eliciting specific disease signs and
symptoms. Until such remodeling has developed, identifying patients at high risk
of adverse cardiac events is extremely difficult. Other complications involve
atherothrombotic events, embolism, peripheral artery disease and many others.
Atherosclerosis progression involves unique characteristic developmental stages,
significant towards development of ideal diagnostic and therapeutic applications.
I will expand on this matter in the next section.

Atherosclerotic plaque vulnerability and instability
The inflammatory process that happens in the atherosclerotic plaque
changes along disease progression and can make the plaque “vulnerable”, or
“unstable”, and then in many cases prone to rupture, ulceration and/or
hemorrhage. At late stages, complications associated with atheroma in the aorta,
coronary and carotid arteries are often irreversible and or life threatening.
The Merriam-Webster dictionary (June 2016) describes “vulnerable” as
open to attack or damage, making it easier to understand the concept of
identifying a harmful process along disease progression. If the evolution of a
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disease follows its natural pathological course, there will be stages in the disease
were the aggressor becomes partially or completely a victim and at this point
"vulnerability" comes into play. The exact time and process to evaluate in such
specific timeline is the main question, where the idea of having a diagnostic tool
that confers anytime in vivo assessment would be of great value.
Atherosclerotic plaque is typically defined in evolutionary progression
trough stages of stability in which the immune components of such process differ.
As plaque progresses, the innate immune response is not able to control the
inflammation and the adaptive immunity is then needed. Plaque features evolve
from an initial small lesion and endothelial dysfunction into a full blown occluding
mass in major arterial vessels. Many of the components of an acute and chronic
immune response inside and adjacent to the plaque overlap, both coexist but
there has to be something else that triggers a plaque to quickly become unstable
and rupture.
Acute phase inflammation is, to some extent, a quicker and more
damaging process than a chronic inflammation. Components of a plaque such as
calcification, remodeling, vascular smooth muscle cell proliferation and slow
progression are more characteristic of a chronic stable plaque. Lipid rich necrotic
core, intraplaque hemorrhage and thin fibrous cap are more specific of an
unstable plaque. The description of such specific feature would be subject of a
more detailed review(Burtea, Ballet, Laurent, Rousseaux et al., 2012;
Seneviratne, Hulsmans, Holvoet, & Monaco, 2013).
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Local and systemic infection has also been directly related to development
of

atherosclerosis

Immunodepressed

in

arterial

patients

also

vessels(Arshinov
exhibit

&

Maslova,

susceptibility

to

2010).

development

atherosclerosis(Campbell & Rosenfeld, 2015), arising to the ability of cytokines
and acute phase reactants as promoters of such accelerated process. Such
studies imply that a plaque is normally a chronic subclinical process that is
triggered to become unstable by an external stimulus that gives the necessary
push for the development of “vulnerability”. Infection and inflammation are tightly
bound and the presence of one will precipitate the presence of the other
(Arshinov & Maslova, 2010). The concept of an atherosclerotic plaque becoming
infected could explain many sides of the discussion about what causes a plaque
to become vulnerable and rupture (Campbell & Rosenfeld, 2015). Recent finding
would agree that the role of polymorphonucleated leukocytes inside the plaque is
the answer to this long standing question (van Leeuwen, Gijbels, Duijvestijn,
Smook et al., 2008).

Animal models of atherosclerosis
Atheroma development is a process that involves the body’s own
immunological response as disease progresses; the extent of successful
vascular

remodeling

and

disease

control

varies

extensively

among

patients(Imanaka-Yoshida, 2012). Such variability complicates the reduction of
fatal outcomes by appropriate disease prevention and diagnosis.
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Many diseases turn the attention into prevention or aggressive therapy,
but some etiologies may not clearly benefit from either of those strategies,
because of specific epidemiologic distinctions(Coste, 2001). Many of the risk
factors for atheroma development include exogenous modifiable factors that
could normally be changed or eliminated (Alavantic & Djuric, 2006), but the
variability of an extensive identifiable number of risk sometimes makes it hard to
appreciate and assess in a patient with a relatively normal medical history and
with little to no risk factors. Animal models of atherosclerotic disease are
inducible and have a strong correlation to human conditions that have distinctive
genetic alterations(Gaut & Heinecke, 2001).
Humans share many mutations with animal models especially with rodents
in which specific transgenic mutations guide atherosclerosis development in such
biological models. Apo E lipoprotein and low-density lipoprotein receptor (Ldlr)
(Silvola, Laitinen, Sipila, Laine et al., 2011) are the most important mice models
that development spontaneous atherosclerotic lesions because of dyslipidemia
(Y. J. Choi, Roberts, Wang, Geaney et al., 2012). Such mutations have inducible
components that are advantageous for scientific research(von Rossum, Enns,
Shi, MacEwan et al., 2014). Atherosclerotic plaque characteristics in a mouse
model

become

evident

over

a

different

time

course

development(Fenning & Wilensky, 2014; Nakata & Maeda, 2002).
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of

disease

Leukocyte Function Associated Antigen-1 (LFA-1)
The integrin composed of a heterodimeric structure of CD11a/CD18,
because of cluster of differentiation also known as LFA-1 is expressed strictly in
leukocytes and is mostly found in mature circulating cells.
LFA-1 mediates leukocyte adhesion, rolling and transmigration (Chigaev & Sklar,
2012a) by a direct complex formed with the intracellular adhesion molecule 1
(ICAM-1) expressed in endothelial and dendritic cells(Collins, Velji, Guevara,
Hicks et al., 2000). Endothelial activation and vascular permeability directly affect
the recruitment of leukocytes to site of inflammation (Chigaev & Sklar, 2012b), in
this case atherosclerotic plaque.
Three stable configurations of LFA-1 have been identified by low affinity
“bent”, intermediate-affinity and high-affinity state(Giagulli, Scarpini, Ottoboni,
Narumiya et al., 2004) upregulated by CXCR2 and PSGL inside out signaling.
The regulation of such receptor has been identified in the process of antigen
presenting cell interaction with major immune cell subtypes(Larson, Davis,
Bologa, Semenuk et al., 2005). T cells are especially effective at upregulating
through the T cell receptor the number and high affinity state (Chigaev, Smagley,
Haynes, Ursu et al., 2015) of LFA-1 receptors expressed in cell surface(Y. Wang,
Shibuya, Yamashita, Shirakawa et al., 2008). LFA-1 as many other adhesion
molecules work in the transport of such cells to site of action and in conjunction
makes an efficient way for leukocytes to be recruited.
Neutrophils are important in the immediate innate response of the
immunity that is also guided by LFA-1 activation, guided by intracellular co-
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activators such as Talin-1 and Kindlin-3(Lefort & Ley, 2012). LFA-1 is then an
ideal target with the desired specificity to illustrate the inflammatory process in
atherosclerotic process with also important application in many other diseases
with an important inflammatory process (Yee, 2000).

BIRT 377 and DANBIRT
The small molecule BIRT 377 is an enantiomer (molecular weight of
442G) allosteric inhibitor of LFA-1. BIRT 377 has been shown to inhibit the low
bent affinity state in the I-domain of the alpha chain of CD11a(Kelly, 2015). Many
attempts have been made to exploit such effects in therapeutic blood
malignancies. This is the case of BIRT, which was developed to target leukemia
and lymphoma treatments (Chigaev, Smagley, Zhang, Waller et al., 2011).
Unfortunately, at pharmacologic therapeutic levels the drug exhibited a poor
safety profile with lung toxicity and was not used in clinical trials.
DOTA(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) functions
as a bifunctional chelator to DANBIRT structure: DOTA-Alkylamino-NorBIRT
(DANBIRT), which is a chemically restructured radioligand capable of binding to
LFA-1 antigen expressed by leukocytes (molecular weight of 885.6G). DANBIRT
has been shown to bind to human and murine hematopoietic cells that express
LFA-1 with a dissociation constant (Kd) of 135nM and 186nM respectively(Rahul
B. Poria, 2006). DANBIRT chemical structure allows the ability to radiolabel such
small

molecule

via

chelation:

[Radiometal]-DOTA-1-(4-aminobutyl)-5-(4-

bromobenzyl)-3-(3,5-dichlorophenyl)-5-methylimidazolidine-2,4-dione. DANBIRT
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value is conferred due to its non-ionic intravenous binding form and its molecular
weight, which confers rapid distribution, LFA-1 binding and excretion. The value
of [111In] In-DANBIRT is further enhanced by the restricted expression of LFA-1
exclusively in leukocytes (Weitz-Schmidt, Welzenbach, Dawson, & Kallen, 2004)

Translational molecular imaging
Nuclear medicine comes to mind when we have to trace a physiological
response of a tissue without a pharmacological response or detectable effect.
The diagnostic and therapeutic advantages of nuclear medicine are believed to
overcome standardized clinical procedures in specific diseases, just by implying
that we can investigate a system without having a response. Working with
invasive procedures can help increase efficiency and improve outcomes of this
disease but invasive is not always a favorable method. Diagnostic nuclear
medicine only accounts for 1.9% of all diagnostic tests performed in developed
countries, with an even lower number of applications in therapeutic nuclear
medicine.
The body will try to reach homeostasis by any means possible, by
regulating any damaging or harmful process that could deteriorate equilibrium.
The extent of the regulation can also affect the "vulnerable" stage of a disease
and decrease the impact and relevance of important diagnostic imaging tests.
Medical manipulation limit is reached whenever a positive outcome is exceeded
by severe complications like thromboembolism, plaque rupture or co-infection.
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Risk stratification in cardiovascular diseases helps dictate how aggressive we
can be in therapeutic strategies.
There are limited commercially available radiopharmaceuticals that can be
employed for the purpose of specifically identifying inflammation in life-threating
situations. Gallium and Indium are two relevant radioisotopes used because of
availability, desired decay emissions and effective labeling methods working with
DANBIRT.

67

Ga and

111

In both have half-lives close to 3 days, decay by electron

capture and are cyclotron-produced; Gallium and Indium have been used in
diagnostic imaging of blood malignancies and for radioimmunodiagnosis by
labeling antibodies respectively.

67

Ga was historically used in nuclear medicine

as a SPECT agent to diagnose Hodgkin’s disease, lymphoma and inflammatory
disease especially in cases of unknown fever.

111

In oxyquinolone (oxine) is

another important clinical radiopharmaceutical used for radiolabeling of
autologous leukocytes but has limitations because of the process of extracting
and isolating patient’s leukocytes for radiolabeling before being re administered
to the patient. The sensitivity of such test is limited to soft tissue infections and its
relevance in nuclear medicine is mostly exceeded by other tests.
Some other imaging tests come to mind such as angiograph that has high target
sensitivity and direct implication in diagnostic and therapeutic cardiology, but is
invasive to name some of the limitations. There is currently no commercially
available similar imaging diagnostic test with the potential and capabilities of
[111In] In-DANBIRT.
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The purpose of this study is to validate [111In] In-DANBIRT as a noninvasive diagnostic tool using SPECT/CT imaging for inflammation assessment
in vulnerable atherosclerotic plaque in a mouse model.
Hypothesis: [111In] In-DANBIRT is an in vivo non-invasive SPECT/CT
imaging probe targeting the expression of LFA-1 in the inflammatory process of
the developing atherosclerotic plaque.
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Chapter 2. “LFA-1 targeting with [111In] In-DANBIRT: in vivo SPECT/CT
imaging of Inflammation in Atheroma Development”
Roberto Mota1, Jeffrey P. Norenberg1,2, William Garver3, Tamara Daniels1,
Monique Nysus1, Selita N. Lucas4, Matthew J. Campen4
1 Radiopharmaceutical Sciences, University of New Mexico, College of
Pharmacy, Albuquerque, New Mexico
2 Anesthesiology & Critical Care Medicine, School of Medicine, University of New
Mexico, Albuquerque, New Mexico
3 Department of Biochemistry & Molecular Biology, School of Medicine,
University of New Mexico, Albuquerque, New Mexico
4 Pharmaceutical Sciences, University of New Mexico, College of Pharmacy,
Albuquerque, New Mexico
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INTRODUCTION
Atherosclerosis is a chronic cardiovascular disease common in patients
exhibiting hypercholesterolemia(Arai, Hirose, Yamamura, Kimura et al., 2002).
The number of adults with diagnosed heart disease has been estimated to be
26.6 million (11.3%) in the US(Blackwell DL, 2012), with more than half of those
patients associated and potentially causal atherosclerotic disease. Prevention
and early diagnosis of atherosclerotic disease complications is a top priority in
modern medicine(Bykov, Chernyshev, Vartazaryan, & Lobastov, 2015), as early
lifestyle and medical interventions can slow the rate of atheroma development
and avert adverse cardiovascular sequelae. Early stage diagnosis is challenging,
however; symptoms often become clinically evident only at late stages where
complete prevention is no longer viable(Jie Sun, Niranjan Balu, Daniel S. Hippe,
Li Dong et al., 2013). As vascular disease progresses, the inflammatory and
remodeling process also evolves, and the plaque can become unstable or
vulnerable to erosion or rupture, which in turn initiates life-threatening thrombotic
outcomes. The penultimate pathological event, plaque rupture, is identified due
to thrombogenic processes and immune cell infiltration(S. Y. Choi & Mintz, 2010).
Histological changes in a vulnerable plaque such as thin fibrous cap, intraplaque
hemorrhage and/or a lipid-rich necrotic chore (LRNC) are present in ~80% of
ruptured plaques, but such manifestations require a prolonged and variable time
for progression(ten Kate, Sijbrands, Valkema, ten Cate et al., 2010).
Cardiovascular inflammation(Hansson, Robertson, & Soderberg-Naucler, 2006)
and remodeling due to atherogenic progression(Imanaka-Yoshida, 2012) have
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also been identified as leading causes of plaque instability, despite incomplete
understanding of these complex process(Nakata & Maeda, 2002). The
Apolipoprotein-E deficient (ApoE-/-) mouse model on HFD exhibits rapid
development of atheromatous plaques(Johnson, Carson, Williams, Karanam et
al., 2005), with features and stages that mirror those of the human
disease(Sasaki, Kuzuya, Nakamura, Cheng et al., 2006). Early stages of
atherosclerosis typically include altered homeostasis and activation of the
vascular endothelium, typified by a loss of nitric oxide generation and increased
expression of chemokines and adhesion molecules (Dimastromatteo, Broisat,
Perret, Ahmadi et al., 2013), which is evident in the ApoE-/- model(O'Brien, 1993).
The role of T cells and monocytes recruited to the plaques and perivascular
regions have been studied extensively in the vascular immune response, but the
ability to identify intraplaque presence and extent of specific leukocyte subtypes
is

mostly

limited

to

invasive

and/or

post-mortem

or

post-resection

imaging(Sadeghi, 2006; Sadeghi, Glover, Lanza, Fayad et al., 2010; Willem J. M.
Mulder, 2014). The role of intraplaque neutrophil accumulation has been recently
identified as a focus point in atherosclerotic plaque vulnerability(van Leeuwen,
Gijbels, Duijvestijn, Smook et al., 2008). Elevation of typical biomarkers for
disease progression is exploited by molecular imaging(Hong, Gona, Fontes,
Oyama et al., 2013), which is limited at the same time because of the low
specificity of current diagnostic tools.
DANBIRT was developed by chemical repurposing of BIRT 377, which is a
specific therapeutic agent for leukemia and lymphoma, as it targets LFA-1
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expressed on both B and T-cells(Horst, Radaszkiewicz, Hooftman-den Otter,
Pieters et al., 1991). Developed targeted ligand, DANBIRT, is a small non-ionic
compound that acts as an allosteric inhibitor of LFA1(Yee, 2000). The importance
of LFA-1 is critical for the initiation and impulse of a vascular immune response to
injury(Kelly, 2015). LFA-1 is involved in specific interaction with Intracellular
Adhesion Molecule-1 (ICAM-1) in endothelial cells by which transmigration is
achieved(Shaw, Ma, Kim, Rao et al., 2004). Radiolabeling DANBIRT using

111

In

(Figure 1) allows co-localization of the radiopharmaceutical in cardiovascular and
immune tissues(Silvola, Laitinen, Sipila, Laine et al., 2011).
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Figure 1. DANBIRT chemical structure and molecular weight.
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The aim of this study is to assess the inflammatory process in atheroma
development within cardiovascular tissues, by assessing leukocyte presence and
accumulation in vascular atherosclerotic plaque in an ApoE-/- mouse model as a
preclinical validation for the use of [111In] In-DANBIRT as a non-invasive
diagnostic imaging tool.

MATERIALS AND METHODS
Animals
Male Apo-E-/- mice on a C57BL/6 background (Taconic Laboratories,
Indianapolis, IN) aged 6 weeks were housed two per cage and allowed to
acclimate over the course of one week after delivery. Mice were fed either a
normal chow diet or HFD (Harlan-Teklad, TD.88137: 1.5g/kg of cholesterol and
42% kcal from fat) for 8 weeks; food and water were provided ad libitum. Food
was changed every 3 days and stored at -20°C and thawed before administration
to the mice. For isolated blood distribution studies, male Sprague Dawley rats
(Taconic Laboratories, Indianapolis, IN) aged 6-8 weeks were allowed 1 week of
acclimation following delivery. Rats were housed two per cage and given food
and water ad libitum. Both rats and mice were maintained on a 12h light:dark
schedule

in

AAALAC-approved

facilities,

and

euthanized

via

cardiac

exsanguination while under deep anesthesia with Isofluorane (Piramidal
Healthcare, NDC 66794-093-25). The UNM Institutional Animal Care and Use
Committee (IACUC) approved all procedures performed. Animal experimental
design is summarized in Table 1.
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Table 1. [111In] In-DANBIRT animal study design. ApoE-/- mice were exposed
for 8 weeks to either normal chow or high fat chow for experiment samples.
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Serum lipid levels and sub particle analysis
Mice were euthanized after 8 weeks of normal or HFD; whole blood was
collected by direct cardiac puncture using a 24-gauge needle coated with 100IU
of Heparin (Sagent, WH0127N). Blood was centrifuged for 15 minutes at 1000g
at 4oC, serum was isolated from other blood components and transferred to
individual Eppendorf tubes with no added anticoagulant and frozen at -20oC.
Serum was analyzed for total cholesterol and triglyceride level, as well as size
dependent sub-particle quantification (Skylight biotech, Liposearch).
Radiolabeling of DOTA-Alkylamino-NorBIRT (DANBIRT) with 111In and 68Ga
DANBIRT was radiolabeled using either

68

Ga or

111

In with a determined specific

activity of 625mCi/pM and a concentration of 1µg:1µL. Indium chloride was
obtained

from

General

Healthcare, INS.1PA) and

Electric
68

Radiopharmaceutical

Department

Ga was eluted from an Eckert and Ziegler

67

(GE

Ge/68Ga

generator using 0.01M HCl. The pH was assessed for acidic concentration of
radionuclide solution using a BAKER-pHIX color-fixed indicator stick (J.T. Baker,
4394-01) as well as activity and volume. The volume of stock solution necessary
for desired labeling activity is calculated, buffer is added to the solution before
adding DANBIRT. Amount of DANBIRT needed for every 4mCi of

111

In or

68

Ga

for radiolabeling was determined to be 6µg of DANBIRT (M.W. 886.5 G/mole).
The reaction vial is buffered using a pH range of 4.0 - 4.5 with addition of 4mM
ammonium acetate (J.T. Baker, 0599-08) for

111

In and a pH of 4.5 for

68

Ga. The

reaction vial was heated in a hot block at 100oC for 35 minutes, vortexing every
10 minutes. Quality assurance was performed with Instant thin layer
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chromatography (ITLC) and High Pressure Liquid Chromatography (HPLC)
following methods by Poria et al (Rahul B. Poria, 2006).
In Vitro Stability of Radiolabeled DANBIRT
Incubation of [68Ga] Ga-DANBIRT with Fetal Bovine Serum (FBS) (Atlanta
Biologicals, S11150) and 0.9% saline solution was performed in vitro stability
analysis. Triplicate samples were drawn from radiolabeled stock and kept
incubated at 37oC until time of analysis. ITLC was performed once at each time
point and HPLC assessment was performed in triplicates at baseline, 5, 10, 30,
60, 120 and 240 minutes of incubation. The mean incorporation yield and
radiochemical purity were calculated from sample results. Following methods by
Poria et al (Rahul B. Poria, 2006) methods were modified for use in a UltraPerformance Liquid Chromatography (UPLC) using an Acquity UPLC BEH C-18
1.7µm column (2.1x50mm) (Waters Corporation, 186002350). UPLC gradient
with flow rate is described in Table 2.
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Time (min)

% Solvent B

Flow (ml/min)

1

0.00

50.0

0.800

2

0.15

50.0

0.800

3

3.00

60.0

0.800

4

5.00

80.0

0.800

5

7.00

100.0

0.800

6

7.50

100.0

0.800

7

8.00

0.0

0.800

8

8.50

0.0

0.800

9

8.60

50.0

0.800

10

9.00

50.0

0.800

Table 2. UPLC method gradient with flow rate

24

Biodistribution of [111In] In-DANBIRT
Upon completion of 8 weeks on normal or HFD, mice were euthanized 3 hours
post-injection of 700µCi of [111In] In-DANBIRT via tail vein; organs were
harvested for weight assessment and [111In] In-DANBIRT uptake using an
Automatic Wizard 2 Gamma counter (Perkin Elmer). Organs collected were: tail,
whole blood, aorta (from aortic arch to thoracic aorta), carotids (from aortic arch
to bifurcation), heart, liver, muscle and adipose tissue.
Whole blood was collected with direct cardiac puncture of right ventricule using a
24-gauge needle of right ventricle with a heparinized syringe and centrifuged for
15 minutes at 1000g at 4oC. Serum, erythrocytes (RBC) and leukocytes (WBC)
containing isolated samples were collected and measured for [111In] In-DANBIRT
uptake using a gamma counter. Uptake was decay-corrected and percentinjected activity per gram (%IA/gr) was determined for each mouse.
Ozone Exposure and Blood Component Distribution
Rats were exposed to either filtered air (FA) or ozone (1.0 ppm) for 4 hours using
an OREC silent arc discharge ozone generator (Osmonics, Phoenix, AZ); ozone
concentrations were continuously monitored over the course of 4 hours.
Exposures took place in a chamber without bedding to minimize ozone scrubbing
and to ensure consistent nasal exposures. Whole blood was collected 24 hours
post-exposure. Histopaque two-step gradient (Sigma Aldrich, 10771) neutrophil
isolation protocol was performed following manufacturer’s methods; modified
protocol was included for PBMC isolation. Hetastarch at 5% (B. Braun, L6511)
was added to whole blood before running isolation protocols. Cell samples were
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washed and suspended in 1% Gelatin in PBS at a pH of 7.2. Final volumes of
neutrophil and PBMC samples were increased to 1mL. Final samples were
identified as serum, RBC, neutrophils and PBMCs and incubated for 1 hour with
[68Ga] Ga-DANBIRT (specific activity of 625mCi/pM). Sample smears were
performed and stained with Wright-Giemsa horizontal staining protocol according
to manufacturer instructions (Sigma Aldrich, SLBN4704V). Cell morphology,
differentials and sample purity were assessed using a light microscope at 40x
objective (Olympus BX51).
Radioisotopic Dilution Methods
Radioisotopic dilution methods were performed with log-fold serial dilutions at
concentrations of 1:1, 1:10, 1:100 and 1:1000 radiolabeled DANBIRT. Rat whole
blood was collected and incubated for 10 minutes with [111In] In-DANBIRT.
Leukocyte isolation was performed for neutrophil and PBMC separations postincubation with radiolabeled DANBIRT (specific activity 625mCi/pM). Cytospin 2
(Shandon 2,59900002) with double-funnel and white filter (Simport, 930941126)
was used for clustered cell differentials identification methods. Cytospin samples
were spread in Superfrost Plus slides (VWR, 48311-703) and fixed with 5%
methanol. Wright-Giemsa horizontal staining protocol was performed according
to manufacturer’s package insert instructions (Sigma Aldrich, SLBN4704V). Cell
morphology, differentials and sample purity were assessed using a light
microscope at 40x objective (Olympus BX51).
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3hr [111In] In-DANBIRT SPECT/CT imaging and analysis
Animals were imaged at 0, 4 and 8-weeks following 700µCi via tail vein injection
of [111In] In-DANBIRT. Imaging was performed using 45 minute acquisitions on a
NanoSPECT/CT® dedicated small-animal imaging system (Bioscan, Inc.
Washington, DC) with specific topogram and SPECT parameters (Table 3) while
animals were in deep anesthesia with isofluorane (Piramidal Healthcare, NDC
66794-093-25). Regions of Interests (ROI) were determined and drawn using the
best quality image phantom from reconstructed CT (Table 3) to determine
muscle, adipose, heart, aortic arch and descending aorta organs using
VivoQuant 2.00 (inviCRO, Boston, MA). The ROI were extrapolated from
phantom scan image onto every image and adjusted according to specific
morphologic parameters. Concentration and sum per volume normalized to
muscle was determined to identify accurate measurements and eliminate ROI
signal interference from adjacent tissues. Activity was decay corrected and
compared between and among dietary groups.
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Table 3. SPECT/CT imaging parameters.
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24-hour [111In] In-DANBIRT 3D autoradiography and image analysis
Mice were euthanized by CO2 method after 8 weeks of dietary assessment. After
removal of limbs, ears, tail and whiskers carcasses were individually frozen in a
hexane/dry ice bath and embedded vertically in a mold by adding an aqueous
solution of 5% carboxymethylcellulose sodium salt (CMC) (C5678, Sigma, St.
Louis Mo) in a hexane/dry ice bath. Block was stored at least 12 hours at -20°C
prior to removal from mold and mounting on a specimen stage in the
cryomacrotome (Leica CM3600 X, Leica Biosystems, Nussloch, Germany).
Multiple 1/8-inch holes were drilled in the CMC block adjacent to the carcasses
and filled with a solution of black India ink and

14

C (1µCi/mL) to provide

registration marks to allow linking the white light block images with the
autoradiography images. The carcasses were cut in 50µm sections in the vertical
plane, starting from below the ear location. Prior to cutting each section, a digital
photo was taken (Canon EOS 70D Focal Length of 35mm, Melville, NY) of the
block surface. Every 10 slices, a section was transferred to 2.5 mm Label Guard
Protection Tape (Scotch 3M 821, DeKalb, IL) and dehydrated in the
cryomacrotome for a minimum of 24 hours. After a total of 55 sections,
autoradiography was taken and accompanied by approximately 600 white light
photos. Cryosections were removed and mounted on black cardboard along with
a set of calibration standards prepared from the radiolabeled DANBIRT, serially
diluted in 1% CMC, and sectioned from a separate block. Dehydrated sections
were covered with 1.4 µm Isotope Imaging Film (FlushTec, Hemet, CA) and
placed on Fujifilm Imaging Plates (BAS-IP SR 2025, GE Healthcare, Piscataway,
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NJ) and exposed for 24 hours in a lead chamber (Raytest, Straubenhardt,
Germany) with 0.04” lead sheeting between each screen cassette. Screens were
imaged on a Phosphorous Imager Typhoon FLA 7000 (GE Healthcare,
Piscataway, NJ). Autoradiography and white light files were compiled and
analyzed using VivoQuant 2.00 (inviCRO, Boston, MA). Determined ROI were
drawn using the best quality image phantom from reconstructed CT (Table 3) for
the thymus, muscle, carotids and aortic arch. The ROI were extrapolated from
phantom scan into every image and adjusted according to specific morphologic
parameters.
Histologic analysis
ApoE-/- mouse hearts were collected, perfused and snap frozen in liquid nitrogen
and stored at -80oC. The upper third of the heart with the aortic outflow tract were
mounted in optimal cutting temperature (OCT) compound for sectioning.
Cryosectioning was performed on OCT heart blocks using a Leica CM 3050S
Cryostat at -20oC for collection of 10µm sections from the subaortic leaflet region.
For Oil Red O staining (Sigma-Aldrich, O0625, SLBP5248V), slides were left at
room temperature for 10 minutes and incubated with Oil Red O working solution
and counterstained with Mayer’s hematoxylin (Sigma-Aldrich, SLBPG176V)
following manufacturer’s staining protocol. Surface lesion area and arterial vessel
circumference were quantified using Olympus cellSens Standard 1.13 to
calculate percentage of atheroma lesion area by arterial wall circumference.
Quality control assessment was performed to compare intensity of Oil Red O
staining between groups.
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Immunohistochemistry
The OCT embedded frozen sections (10µm) were fixed in methanol for 10
minutes at -20°C. After washing in PBS, the sections were incubated with
fluorescein

isothiocyanate

(FITC)

conjugated

rat

anti

mouse

CD11a

(SouthernBiotech S1555-02) antibody (1:250) for 2 hours in a humidifier
chamber. Sections were counterstained with DAPI (1:1000 dilution), imaged at
10x and 63x using a Fluorescence Microscope (Zeiss AxioObserver-Hamamatsu
Flash4.0 sCMOS Monochrome Camera), image reconstruction was performed
under FITC (490 Ex, 525Em) channel. Image processing was performed using
Olympus cellSens Standard 1.13.
Statistical Methods
All statistics were computed using two-tailed Student’s t-tests, or one-way and 2way factorial ANOVA. Tukey’s post-hoc test and Sidak's correction test were
used for multiple comparisons. Resulting p-values <0.05 were considered
significant. The results from 3D autoradiography results were compared as a
mean difference in quantitative uptake reflected as %IA/gr normalized to muscle
of radiolabeled DANBIRT because of limitations in compatibility of

111

In

radioactive standards in this pilot study. GraphPad Prism 6.0 software for mac
(GraphPad Software, Inc.) was used for all statistical analyses.
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RESULTS
Radiolabeling and in vitro characterization of [111In] In-DANBIRT
DANBIRT was efficiently labeled for experiments using

111

In and

68

Ga, achieving

high in vitro stability. Assessment reflected >99% incorporation yield by ITLC and
>99% radiochemical purity by HPLC analysis. Triplicate serial samples of
radiolabeled DANBIRT incubated with fetal bovine serum (FBS) and 0.9% saline
solution showed >95% mean radiochemical purity using UPLC method and
>97% mean incorporation yield using ITLC method. Stability of [111In] InDANBIRT was maintained throughout 4 hours of incubation (Figure 2).
Ex vivo biodistribution of [111In] In-DANBIRT post tail vein injection
From biodistribution analysis of [111In] In-DANBIRT, liver samples showed high
uptake when compared to other tissues regardless of dietary treatment. Liver
inspection after dissection revealed a pale white color with fibrous consistency in
all HFD fed mice but not evident in normal diet fed mice, suggestive of steatosis.
Serum samples also showed a high uptake compared to other blood
components, similar only of those levels from liver samples. Cardiovascular
tissues (heart, aorta, carotids) reflected higher uptake in animals that were fed a
HFD (p<0.05).
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Figure 2. Radiolabeled DANBIRT in vitro stability. Representative HPLC (A)
and ITLC (B) results were performed to assess in vitro stability after radiolabeling
protocol for 68Ga was completed. (C) Incubation in Fetal Bovine Serum (FBS)
and 0.9% Saline solution showed >95% mean radiochemical purity and
incorporation yield in triplicate samples at baseline, 5 minutes, 30 minutes, 60
minutes, 120 minutes and 240 minutes of incubation.
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Similar findings were found in RBC and WBC samples with increased uptake in
HFD fed mice compared to normal diet fed mice (p<0.05) (Figure 3). Distribution
of [111In] In-DANBIRT showed an increase in %IA/gr of tissue in animals that
were fed a HFD in comparison to animals fed a normal fed diet (p<0.05).
Metabolic effects in ApoE-/- mouse model after 8 weeks of HFD
Biological model was guided by mice ApoE deficiency that were placed on a
HFD, resulting in an increased percent weight gain per week compared to
animals in a normal diet (p<0.05) (Figure 4). Serum lipid levels and subparticle
analysis showed that total cholesterol levels were higher in HFD fed mice, and
higher levels of total triglycerides in normal diet fed mice; VLDL-Cholesterol and
HDL-Cholesterol were also statistically different between dietary groups (p<0.05)
(Figure 5). These results confirm the dietary effects in this model.
Histologic and immunohistochemical analysis of aortic atherosclerosis
development
Histologic analysis reflected an accumulation of inflammatory tissue in the
subaortic leaflet region of ApoE-/- mice. Histologic analysis of OCT frozen
cryosections showed a higher percentage of atherosclerotic lesion area in
relationship to vessel wall area in HFD fed mice compared to normal chow fed
mice (p<0.05) which were correlated by Oil Red O staining for lipid accumulation.
Oil red O staining quality control and assessment also reflected higher intensity
of tissue staining area in HFD fed mice compared to normal fed mice (Figure 6).
Immunohistochemistry was performed using anti-CD11a (LFA-1) antibody to
identify qualitative atherosclerotic intraplaque CD11a+ leukocytes (Figure 7).
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Figure 3. Biodistribution analysis of [111In] In-DANBIRT on ApoE-/- mice
after 8 weeks of dietary assessment. Muscle, heart, aorta, serum, WBC and
liver were harvested and uptake was quantified. Results showed higher uptake in
cardiovascular tissues and leukocytes in mice that were fed a HFD (p<0.05).
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Figure 4. Percentage weight gain per week from baseline weight of ApoE-/mice after 8 weeks of dietary assessment. Percentage of baseline body
weight increase compared at weekly time points represented as weeks per
dietary group.
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Figure 5. Serum total cholesterol and triglyceride level quantification in
ApoE-/- mice per dietary group. Total cholesterol, total triglyceride, VLDL, HDL,
LDL and chylomicron quantification are expressed as concentration in milligrams
per deciliter (mg/dL) and in nanometers (nm) for particle size.
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Figure 6. Histologic analysis of OCT frozen subaortic leaflet atherosclerotic
lesions. Oil red O staining of histologic sections of OCT frozen subaortic leaflet
atherosclerotic lesions under a 10x objective, represented as percentage of
atheroma lesion area to arterial vessel wall area (µm2) per dietary group.
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Figure 7. Immunohistochemistry of OCT frozen subaortic leaflet
atherosclerotic lesions. (A) FITC conjugated rat anti-mouse CD11a (10x
objective) (B) compared to Oil Red O staining of consequent slides in HFD fed
animals (10x objective). (C) Subaortic vessel wall leaflet atherosclerotic
lesions stained with FITC conjugated rat anti-mouse CD11a
(63x objective w/immersion oil)
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LFA-1-specific

targeting

and

competitive

leukocyte

binding

with

radiolabeled DANBIRT
Leukocyte isolation methods successfully identified purity of samples, with
predominance of immature neutrophils (~59%) and PBMCs (~53%) in ozoneexposed rats (used to induce a circulating neutrophilia, as previously
described(Paffett, Zychowski, Sheppard, Robertson et al., 2015)) with no other
relevant morphologic cell changes. Data showed an increased uptake of [68Ga]
Ga-DANBIRT in neutrophils (*p=0.008) (Figure 8), with a decreased uptake in
PBMCs post-ozone exposure.
Log-fold dilution concentrations of [111In] In-DANBIRT identified a competition for
LFA-1 receptor binding in target leukocytes. Incrementing radiolabeled DANBIRT
concentration resulted in competitive binding, identifying a saturation of binding
sites in neutrophils starting at a 1:10 log-fold serial dilution concentration of [111In]
In-DANBIRT (Figure 9). A pattern of 50% decreased initial uptake after each log
fold dilution concentration was evidenced in serum, RBC and PBMC samples.
PBMCs at different dilution concentrations did not evidence any saturation levels
or reflected a tendency when compared to neutrophil sample (p<0.05).
Longitudinal molecular imaging of cardiovascular LFA-1 presence with
[111In] In-DANBIRT
The 3hr [111In] In-DANBIRT SPECT/CT imaging showed a longitudinal increased
uptake in heart, aortic arch and descending aorta ROI concentration
quantification in the 4th and 8th week time points in HFD fed mice (Figure 10).
The 24hr [111In] In-DANBIRT 3D autoradiography allowed a functional and more
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advanced anatomical assessment of the presence of inflammatory LFA-1 in
immune and cardiovascular tissues, an essential finding to characterize the
biological model. Mice fed exhibited an increase in carotids and thymus’s
concentration per volume normalized to muscle in HFD fed mice compared to
normal diet fed mice (Figure 11).
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Figure 8. Radiolabeled DANBIRT uptake in isolated blood components post
4-hour exposure to ozone. Data showed an increased uptake of [68Ga] GaDANBIRT in neutrophils post 4-hour ozone exposure (*p=0.008) with a decrease
in PBMC and serum uptake. Cytospin slides were stained using Wright-Giemsa
horizontal method for differential analysis of isolated sample purity under 100x
objective w/immersion oil with a light microscope.
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Figure 9. Radiolabeled DANBIRT competitive binding assays. Radioisotopic
dilution methods were performed using an initial specific activity of 625mCi/pM
and consequent serial log-fold dilution concentrations. Saturation of isolated
neutrophils as of percent of maximum uptake was observed starting at
62.5mCi/pM (1:10X log fold dilution concentration) specific activity of radiolabeled
DANBIRT.
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Figure 10. 3hr [111In] In-DANBIRT SPECT/CT imaging. (A, B, C) Increased
longitudinal uptake of [111In] In-DANBIRT in cardiovascular areas prone to
vascular atherosclerosis development (heart, descending aorta, aortic arch)
reflecting a longitudinal increase per time point (week) shown by SPECT/CT
imaging. (D) ROI were drawn for muscle, descending aorta, aortic arch and heart
using VivoQuant (inviCRO) from phantom scan and extrapolated in each subject.
Red arrows point to ROI of descending aorta.
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Figure 11. 24hr [111In] In-DANBIRT 3D autoradiography. (A,C) ROI were
drawn for muscle (blue), common carotids (green), aortic arch (cyan) and thymus
(red) using VivoQuant from phantom scan and extrapolated in each subject,
reflecting concentration per volume normalized to muscle. (B) Increased uptake
of [111In] In-DANBIRT in common carotids and thymus in HFD fed mice
compared to normal diet fed mice.
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DISCUSSION
The purpose of this study was to determine the value of [111In] In-DANBIRT as a
non-invasive in vivo imaging tool for LFA-1 expression in leukocytes in the
inflammatory process of atheroma development by longitudinal SPECT/CT
molecular imaging. Results showed that we were able to target the increased
LFA-1 expression in neutrophils under an acute systemic immune injury model
(i.e., ozone exposure), used analogously to early inflammatory developmental
stage of vascular atherosclerotic lesions. Longitudinally-increased uptake in
cardiovascular tissues, shown by SPECT/CT, illustrates the translational
component and value in a chronic model. In vivo assessment of atherosclerotic
plaque vulnerability is a clear need in cardiovascular research. Biotechnological
approaches designed to identify, assess, and potentially eliminate fatal
repercussions of atheroma development could have great benefits to
patients(Herrington, Lacey, Sherliker, Armitage et al., 2016). Longitudinal in vivo
imaging of plaque inflammatory processes is a very promising concept to
advance understanding and reduce cardiovascular related complications(Burtea,
Ballet, Laurent, Rousseaux et al., 2012).
The selective expression of LFA-1 in leukocytes and DANBIRT’s small size
contribute to a theoretically ideal imaging probe of inflammatory activity inside of
the plaque. LFA-1/ICAM-1 complex is important in almost every vascular disease
because of its role in leukocyte recruitment and transmigration(Collins, Velji,
Guevara, Hicks et al., 2000). T-cell activation and migration to sites of
inflammation is guided predominantly by LFA-1/ICAM-1 interaction and Signal46

2(Anderson & Siahaan, 2003), making the allosteric inhibition of LFA-1 an
effective way to target intraplaque inflammation(Rahul B. Poria, 2006). Recent
papers address the functionality and sensitivity of LFA-1, understanding that
modulation of this integrin will impact immune progression of disease(X. J. Wang,
Xu, Zhang, Krishnamurthy et al., 2010). Atherosclerosis development is
dependent on the severity of the immune response at sites of vascular injury,
along with the ability to resolve such inflammation (Vestweber, 2007).
Inflammatory components such as leukocytes have major roles in plaque
vulnerability and instability, impacting barrier integrity, releasing peptidases that
facilitate remodeling, and generating pro-inflammatory chemokines. Local and
systemic immune response appears to guide cardiovascular tissue uptake
(Tabdanov, Gondarenko, Hone, & Kam, 2011), while illustrating the potential for
enhancing SPECT/CT interpretative results in a more sensitive and specific
system.
Numerous in vivo imaging strategies are being assessed for effective diagnosis
of atherosclerotic plaque vulnerability. Many other studies have characterizes the
unique plaque characteristics, such as calcium presence and morphology,
without fully addressing the role of neutrophil accumulation in the plaque. Work
performed with DANBIRT and the detection of vascular LFA-1 levels stands as
an attempt to complement other imaging approaches. Novel approaches utilizing
enhanced hybrid imaging systems that target metabolic activity inside of the
plaque to assess glucose uptake in such tissues may further add to a battery of
plaque characteristics that can be more precisely linked to adverse pathological
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outcomes (Riou, Broisat, Dimastromatteo, Pons et al., 2009). Understanding the
role of neutrophils in plaque vulnerability is important(van Leeuwen, Gijbels,
Duijvestijn, Smook et al., 2008), because of the correlation between plaque
instability and the presence of neutrophil-derived acute immune response
markers.
From results we know that radioisotopic dilution methods helped us achieve a
concentration in which the observe competitive binding(Perales, 2015) illustrated
receptor saturation in neutrophils. Saturation in these samples correlates to
findings in the biodistribution and post-ozone exposure data, confirming the role
of [111In] In-DANBIRT for radiolabeling neutrophils at a proven specific activity
and concentration. The increased volume from serum and RBC samples did not
reflect nonspecific binding in these experiments, but did explain the concept of
saturation of LFA-1 binding sites in neutrophils. Another important characteristic
of

111

In (Indium chloride, chemical presentation provided by GE Healthcare) is

that it has high uptake in the liver and lungs because of binding interaction with
transferrin and lactoferrin(Otsuki, Brunetti, Owens, Finn et al., 1989) illustrating
initial biodistribution high uptake levels in the liver. These studies effectively
demonstrated

radiolabeling

radioisotope) and

111

of

DANBIRT

using

68

Ga

(short-lived

PET

In (longer-lived SPECT radioisotope) demonstrating high

stability throughout 4 hours of incubation in FBS and 0.9% NaCl. Through in vitro
stability studies and effective labeling methods it is possible to safely administer
[111In] In-DANBIRT intravenously as a stable radioligand probe.
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The biodistribution of [111In] In-DANBIRT showed a high uptake in the liver,
serum and RBCs, which identified an issue with the binding potential was
postulated as nonspecific uptake due to the mass effect of the radioligand
specific activity. Adipose tissue and muscle were identified as potential low
uptake tissues. Tissues surrounding the vessel lamina adventitia have been
recently identified as sites of accumulation of inflammatory cells in ApoE-/- mice
on a normal diet(Moos, John, Grabner, Nossmann et al., 2005). This effect was
not clearly identified in the studies due to the limits of spatial resolution of the
SPECT imaging system. However, adipose tissue was identified as lacking
significantly different uptake compared to the tissue designated as background
(muscle). These biodistribution results to hypothesize three specific scenarios: no
binding, aspecific binding or free, unlabeled drug. In vitro stability studies showed
that at 4 hours post incubation in FBS and 0.9% NaCl, the radiolabeled
DANBIRT was stabile, eliminating the possibility of free unlabeled drug/ligand
post administration. By blood component isolation and post-ozone environmental
exposure, the target cells were visualized in a proven animal model correlating
with local and systemic acute immune response reflected parallel results from an
innate immune response in the targeted cells(Ramot, Kodavanti, Kissling,
Ledbetter et al., 2015).
Molecular imaging shows a longitudinally-increased uptake in cardiovascular
tissues in mice fed a HFD, which correlates to atherosclerotic development
because of the presence of shear stress areas in principal arterial
vessels(Katakami, 2016). Functional and morphological assessment of [111In] In49

DANBIRT guides the translational component of probe development.
The limitations of these studies included reduced statistical power of the animal
sample, although this was lessened due to the longitudinal collection of repeated
measures data by SPECT/CT. Many mouse models use an ApoE-/- model of
atherosclerosis development because of the resultant hypercholesterolemia and
spontaneous presentation of plaque starting at 3 months of age(Sasaki, Kuzuya,
Nakamura, Cheng et al., 2006). The HFD increases the amount of plaques by 14
weeks of age(Meng, Ma, Yan, Chen et al., 2016). Although deficiency of the LDL
receptor will also cause high levels of lipids and some spontaneous dietdependent plaques, the extent and slow progression of Ldlr deficiency makes the
ApoE-/- model a desireable choice. The use of the wild type control strain
(C57BL/6) was not considered as these mice fail to develop any observable
vascular pathology.

In a translatable approach, humans with hereditary

hyperlipidemia have associated mutations of Ldlr and/or ApoE, which has been
shown to increase the susceptibility to developing atherosclerosis(Mata, Alonso,
Ruiz-Garcia, Diaz-Diaz et al., 2014). Human atherosclerotic plaques resemble
the ApoE-/- mouse model but, the Ldlr deficient mouse model develop a closer
resemblance in the lipidemic panel in humans(Abd El-Aziz & Mohamed, 2016).
From these results, the development of early stage atheroma is includes acute
inflammatory

components.

Histologic

and

immunohistochemical

analysis

supports the findings by characterizing the early development of the
atherosclerotic model. The increased areas of atherosclerotic lesions and lipid
accumulation correspond to results found in the HFD-fed animals. [111In] In50

DANBIRT is a promising radioligand for identification of the presence of LFA-1 in
circulating leukocytes. Accumulation of immune cells in atherosclerotic plaque
lesions mediates disease progression and vulnerability. Vascular atherosclerotic
lesions in areas prone to atheroma development can be characterized by
radioligand uptake. Thus, these findings support future investigation of a more
advanced vascular disease model that will validate [111In] In-DANBIRT as a
diagnostic tool for assessment of inflammation in cardiovascular injury models.
CONCLUSIONS
Characterization of the biologic model identified the early stage development of
atherosclerotic plaque in cardiovascular tissues with an acute inflammatory
component. The longitudinally increase in [111In] In-DANBIRT uptake in
cardiovascular tissues in mice fed a HFD was consistent with histopathologicallyobserved advancement of aortic lesions. Neutrophil and PBMC isolation methods
demonstrated selective and competitive LFA-1 antigen receptor binding in
leukocytes. Radiosotopic dilution and receptor-binding assays evidence a mass
effect in neutrophils with radiolabeled DANBIRT at a specific activity of
<62.5mCi/pM. These correlative results demonstrate competitive and specific
LFA-1 antigen receptor binding to targeted leukocytes.
This study validates the potential of [111In] In-DANBIRT to competitively bind
leukocytes,

especially

neutrophils,

while

illustrating

the

presence

in

cardiovascular and immune tissues identified in a systemic inflammatory
response following exposure to inhaled ozone. Recent publications corroborate
BIRT377

as

a

potential

drug

for
51

clinical

applications

in

high-risk

populations(Kelly, 2015; Rahul B. Poria, 2006). Further studies are needed to
determine the value of this radioligand probe as an in vivo non-invasive imaging
tool in an enhanced chronic vascular injury model exhibiting predominance of
adaptive immunity components.
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Chapter 3. Discussion and conclusion
I will start the discussion by stating the principal aim of this study: Validate
the use of [111In] In-DANBIRT as a novel in vivo non-invasive SPECT/CT
molecular imaging tool in the development of atherosclerotic inflammatory
plaque. I have read the aims over and over again to try to comprehend how such
an important diagnostic tool is not available, and the answer is clear, because it
is a very difficult task to accomplish(Dietrich, Berndorff, Heinrich, Hucko et al.,
2015). There are many sides to the chemical repurposing of DANBIRT, there has
been groundwork done with DANBIRT that actually showed that it is able to bind
to bone marrow hematologic precursors in human and murine cells. In
conjunction with my committee, I was able to come up with the most direct way to
illustrate the value of [111In] In-DANBIRT using nuclear medicine assays,
metabolic assessment, environmental exposure and toxicology in a specific
atherosclerosis approach.
Appreciating that atherosclerosis is a disease that changes and evolves is
the first step to effectively prevent and diagnose its progression(Herrington,
Lacey, Sherliker, Armitage et al., 2016). The immune component of
atherosclerosis shifts dramatically in a short amount of time, challenging the
body’s adaptability. The idea that our own immune cells play a key role in
atherosclerotic plaque rupture and complications is another important concept. I
employed all efforts to try to comprehend the behavior of the radioligand [111In]
In-DANBIRT, and to illustrate the potential for its implementation in different
models of acute immune injury.
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Radiolabeled DANBIRT has been used in the past in a chronic exposure
to Mixed Vehicle Exhaust (MVE) emissions in young (2 month) and old (18
month) mice (Mumaw, Levesque, McGraw, Robertson et al., 2016), The lung and
heart uptake of DANBIRT increased, suggesting a local and systemic
inflammation in young animals exposed to MVEs. This was correlated by
bronchoalveolar lavage fluid results showing an increase in total cell and
neutrophil quantification in young but not old mice after MVE exposure. Such
results highlight the biological model of chronic exposure as a mean to assess
inflammatory modulation over time in animals that have different levels of
immune coherent systems. Under these conditions, it is comprehensible that the
assessment of immune modulation is essential to the local and systemic
inflammatory signaling in cardiovascular diseases (Santarpino, Caroleo, Onorati,
Dimastromatteo et al., 2009).
For many years, environmental exposure research has been one of the
leading fields of focus and will continue to be so because of the inadequate
control for hazardous environmental exposures (Last, Gohil, Mathrani, & Kenyon,
2005; Ramot, Kodavanti, Kissling, Ledbetter et al., 2015). Evaluation of
cardiovascular effects of environmental exposure is easily translatable to multiple
research areas in which the inflammatory components of such biologic models of
disease are easily demonstrated (Sun, Liu, Xu, Ying et al., 2013). LFA-1 targeting
of [111In] In-DANBIRT was also evidenced under an ozone exposure assay and
competitive binding assays to isolated blood components. Environmental
exposure played a key role to illustrate the potential value of this imaging probe.
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Limitations of the Study
Atherosclerosis is a complicated disease in which demonstrating the
correct development of the mouse model is a long and tedious task. I believe the
most important limitation for the thesis project was being underpowered. Many of
the thesis related experiments ideally would have had a larger sample size,
thereby reducing variance as much as possible. Even though these studies were
somewhat underpowered, the analysis was rigorously performed increasing the
amount of assays and experiments that I was able to complete. Having multiple,
repeated measurements in mice, there is high variability from the analysis that
directly affect the study design The animal model of atherosclerosis is difficult to
manage because of the constant monitoring of food intake and adjustments plus
the involvement of competition in mice cages for dominance and other secondary
adverse effects from ApoE deficiency.
Other limitations included DANBIRT determined specific activity for
imaging at low target dose because of proven a proven mass effect, when
working with radioactivity and small molecules, the specificity of the radioligand
to target LFA-1 has to be high. Effective radiolabeling and stability effect
intravenous administration and logically the analysis of image data. Rapid
biodistribution and clearance may also interfere with the natural process of
leukocyte migration and may only target the circulating pool of mature available
leukocytes. The hypothesis was focused in identifying the localization of such
immune cells inside of the plaque to illustrate the longitudinal approach of the
imaging modality(Issekutz, 1995). I had to demonstrate that because I used an in
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vivo model, the in vitro assessment was correlated to the findings while
characterizing an effective evolution of the disease model.
The ApoE-/- mouse model of atherosclerosis has been studied extensively,
although most of the assessment performed is focused on other characteristic
components of a vulnerable plaque(Freitas, Campana, Pozzan, Brandao et al.,
2015). Spontaneous plaque development in ApoE deficient mice has been
described in the literature (Hu, Ma, Huang, Mao et al., 2013) but, it does not
always respond to interventions in the same way (Zalewski & Macphee, 2005). A
larger animal model of disease, such as a rat, may allow more complete
assessment of specific morphologic parameters with a SPECT/CT system.
Initially,

co-administration

of

intravenous

contrast

agents

(gold

nanoparticles with high macrophage uptake, and iodine based contrast agents to
enhance SPECT/CT imaging. Macrophage uptake of contrast agents confounded
the use of such agents because it could potentially interfere from signal acquired
from inside the plaque and disrupt from areas that might have specific
macrophage subsets. Such similar problems were implied with the use of gold
nanoparticles and they were also not used for imaging studies. Iodine-based
contrast agents were tried repeatedly to illustrate the value of enhanced vascular
identification. However, because of the effects on heart rate and cardiac output,
these efforts were unsuccessful in the ApoE-/- mouse model.
The contrast agent was not being observed in the blood pool even at
multiple time points but was present in the kidneys even seconds after
administration. I did increase the aperture for the SPECT imaging scans to try to
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enhance results and have better quality images that illustrate the potential of the
probe. Phantom scans from reconstructed CT was performed to correctly
extrapolate the use of analytic software to localize ROIs in cardiovascular tissues
without the need for a contrast agent (Vemulapalli, Metzler, Akabani, Petry et al.,
2007). I also took many measures to try to decrease the variability between the
mouse model; biased interpretation of longitudinal molecular imaging intra- and
inter-animal error was eliminated by randomized and blind interpretation of image
data from each mouse. Most of the experiments had samples run in duplicates or
triplicates to improve the statistical analysis.
There would have to be substantial evidence to prove the concept of
radiolabeled DANBIRT as a fully translatable imaging diagnostic tool. The
concept has legitimate value, the characterization of the intravenously
administered probe showed great results but, there is still a much needed
implementation of DANBIRT in a Positron Emission Tomography (PET) imaging
system that can translate to clinical imaging. If the effective specific activity of
[68Ga] Ga-DANBIRT is proven to be high enough to find similar results in a
specific chronic vascular disease model that can increase the spatial and
temporal resolution, then I believe we would be in the verge of a new molecular
imaging diagnostic tool for the assessment of cardiovascular disease and risk of
cardiothrombotic events in clinical patients.

Implications for Future Research
There is still work to be done to validate the translatable value of [111In] In-
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DANBIRT, but we are in the right path. Findings from this thesis project and
work done from past students from the radiopharmaceutical sciences program at
the University of New Mexico Health Sciences Center (Rahul B. Poria, 2006)
support investigation of a more advanced vascular disease model that will help
validate [111In] In-DANBIRT as a diagnostic tool for assessment of inflammation
in cardiovascular injury models. The continuously changing inflammatory
components of atherosclerosis development changes the value and/or limitations
of [111In] In-DANBIRT(Henderson, Hobbs, Mathies, & Hogg, 2003). Because of
the intrinsic reliability of performing nuclear medicine procedures in patients, it is
ideal for a radiopharmaceutical to have high reproducibility and diagnostic
sensitivity in multiple applications.
Whether the value of [111In] In-DANBIRT relies on high specificity or
sensitivity,

we

need

to

establish

its

value

in

multiple

scenarios.

Radiopharmaceuticals should have multiple applications in identifying at risk
patients and having a high positive and negative predictive value, with the
potential for improvement. There is a great need in nuclear medicine and
molecular imaging for a diagnostic tool that is able to discriminate the
inflammatory component of a disease in vivo and longitudinally (Gallino, Stuber,
Crea, Falk et al., 2012). It is very difficult for a clinician to evaluate the extent of
inflammation in specific tissues without performing additional diagnostic tests.
Disease models of inflammatory bowel disease, cancer, asthma, lupus
related vasculitis, endocarditis and many other diseases with strong immune and
inflammatory components would benefit from in vivo (Zhao, Yao, Deng, Ju et al.,
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2010) assessment using [111In] In-DANBIRT, evaluating its imaging capabilities in
pre clinical scenarios were longitudinal assessment of immune modulation can
correctly evidence the expression of LFA-1 in specific tissues.
The mouse model was identified as a stage 2 atheromatous vascular
lesion, but it is important to test the value of [111In] In-DANBIRT in more
vulnerable severe plaques. There is a recent concept of development of a shear
stress-related advanced atherosclerotic vascular lesions (Lee, Choi, Seo, &
Yeom, 2015) with the use of a microsurgery for carotid cuff placement performed
with a plastic “cast” around a unilateral carotid artery (Kuhlmann, Cuhlmann,
Hoppe, Krams et al., 2012). The surgery is performed on ApoE-/- mice that are
placed on a HFD for 5 weeks after surgery. Mice develop prominent plaques that
can be observed by physical evaluation after carotid resection (Katakami, 2016).
This model identifies potential vascular zones that are susceptible to
atherosclerotic development and also to rupture due to low and high shear stress
to certain areas around the cast placement. Unstable plaque characteristics such
as: intraplaque hemorrhage, neovascularization (vasa vasorum) and increased
intraplaque immune cell activity that will develop from this model will enhance
result from the longitudinal increased uptake of radiolabeled DANBIRT in
atherosclerotic lesions.
Using DANBIRT as a diagnostic tool to accurately distinguish areas with
significant radioligand uptake (Dimastromatteo, Riou, Ahmadi, Pons et al., 2010)
due to the presence of immune inflammatory components may improve
diagnosis and staging of cardiovascular disease, which, in turn may reduce or
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eliminate the need for unnecessary diagnostic surgery, improper diagnostic
testing, increase the specificity of invasive procedures and reduce overall cost.
Pediatric and elderly patients are examples of patients for whom a thorough
physical evaluation may not provide an adequate assessment of a patient’s
health. The ability of a diagnostic test is to complement the differential
diagnostics that have been determined by a physician (Riou, Broisat,
Dimastromatteo, Pons et al., 2009).
Molecular imaging is an ideal companion for a clinician to reduce
diagnostic uncertainty that might have been present at the time of medical
evaluation. Routine nuclear medicine imaging tests are performed in outpatient
settings with a small number of patients having tests performed as
inpatient(Rybicki, Udelson, Peacock, Goldhaber et al., 2016). Molecular imaging I
spossible because of the lack of interference with the body’s natural biochemical
processes while allowing assess pathology. This last statement may be the
single most important feature to look for when designing or repurposing a
radiopharmaceutical for the ideal imaging system.
I used SPECT/CT imaging with [111In] In-DANBIRT, being able to
efficiently radiolabel DANBIRT with a shorter half-life radioisotope like
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Ga with

high in vitro stability shown by characterization. Ideally, we would like to use
[68Ga] Ga-DANBIRT not as a SPECT agent but as a PET imaging probe because
of its dual value in both imaging platforms. This will be something to look forward
and make DANBIRT a validated probe for imaging inflammatory disease.
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SPECT/CT imaging confers a similar temporal and spatial resolution
(Keenan, Pugliese, & Davies, 2014) to PET/CT in small-animal imaging.
However, in clinical imaging, the larger body-mass of patients requires
attenuation correction, making PET imaging the most researched imaging
modality(Perez-Medina,

Binderup,

Lobatto,

Tang

et

al.,

2016).

Fluorodeoxyglucose (FDG) is a PET imaging radiopharmaceutical that identifies
glucose metabolism in tissues with the ability to discriminate between low,
moderate and high degree uptake areas(Golestani, Mirfeizi, Zeebregts, Westra et
al., 2015). Almost every tissue uses glucose in a both physiologic and
pathological pathway, illustrating the high sensitivity but low specificity of FDG
especially in cardiovascular disease.
Because of the limitations of SPECT, the advantages of hybrid imaging
PET/CT systems would not be greater in terms of the imaging system itself.
Functional imaging of small animals such as mice and rats eliminates the need
for attenuation correction and other resolution compensations between
SPECT/CT and PET/CT imaging(Garrigue, Giacomino, Bucci, Muzio et al.,
2016).

Conclusions
Results from this thesis project showed that ApoE-/- mice on a high fat
“Western” diet exhibit increased cardiovascular and immune tissue uptake of
[111In] In-DANBIRT after 4 weeks of HFD with a longitudinal increase after 8
weeks of HFD compared to mice on a normal diet. 3hr SPECT/CT and 24hr 3D
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autoradiography imaging illustrated a consistent pattern of increased uptake in
cardiovascular (aortic arch and descending aorta) (Schramm, Menger,
Schaefers, & Thorlacius, 2004) and immune tissues in HFD fed mice, evidencing
a positive correlation to the metabolic changes in the biological model that
identifies sites of accumulation of immune cells with a systemic and local
response. Isolated whole blood components evidenced increased specific uptake
in neutrophils after exposure to ozone, indicating that radiolabeled DANBIRT is
able to accurately evidence the acute immune response in the animal model by
targeting increased expression of LFA-1 in neutrophils (Block, Stadtmann, Riad,
Rossaint et al., 2016).
In vivo imaging of LFA-1 expression correlates with vascular lesions from
subaortic leaflet cryosections, while illustrating the increased lipid content in the
development of atherosclerosis in mice fed a HFD. [111In] In-DANBIRT is a
promising radioligand for targeting the presence of LFA-1 in circulating mature
leukocytes, specifically targeting neutrophil increase in the acute immune
response in atherosclerotic plaque due to vascular injury (Nathan, 2006).
Accumulation of immune cells in atherosclerotic plaque lesions mediates disease
progression and vulnerability, were the aortic arch and descending aorta are
most prone to atheroma development can be characterized by the increased
uptake of [111In] In-DANBIRT(Phinikaridou, Andia, Shah, & Botnar, 2012).
This research project has been a fantastic opportunity to integrate one of
the greatest passions I have in my life, translatable research. I have been able to
explore many areas of cardiovascular and immunopathologic research in
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atherosclerosis while implementing a novel approach to an ancient problem. It is
fundamental in modern medicine to outreach and collaborate between different
areas of biomedical research. The field is positively impacted whenever young
investigators are encouraged to try novel approaches to known problems in
health. The extent of these results will benefit future research to be conducted
with DANBIRT and will make room for better and transcendental work in my
career. I am grateful for everyone that had a part in this research project and that
made an impact in my research career.
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Appendices
3D blocking autoradiography was performed to demonstrate the anatomical and
functional biodistribution of [111In] In-DANBIRT in wild type mice, blocked (preadministered with 1,000X IV dose of cold DANBIRT) and unblocked C57BL6
male mice (n=3 per group) 24 hours post injection of 100µCi of [111In] InDANBIRT. Image processing of autoradiography images was performed to allow
and analysis by region of interest (ROI) determination in relationship to
concentration per volume; values were decay corrected and normalized to
muscle uptake; percentage injected dose per gram of tissue (%ID/gr) was
calculated from ROI quantification.
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There were no significant differences in the lungs or liver uptake between groups
with a slight increased uptake in the unblocked kidneys (A), correlating to
longitudinal molecular imaging and biodistribution results from past studies with
[111In] In-DANBIRT. High uptake in unblocked immune-competent lymphoid
(thymus, spleen) (B) and cardiovascular tissues (heart, thoracic aorta, right
carotid, aortic arch) (C), directly illustrate high specificity in LFA-1 expressing
resident and circulating leukocytes, targeted in vivo using [111In] In-DANBIRT.
3D

blocking

autoradiography

showed

the

functional

and

anatomical

biodistribution of [111In] In-DANBIRT in cardiovascular (heart, aortic arch,
descending aorta, carotids) and immune tissues in unblocked mice indicating
specificity for LFA-1 expression in target tissues.
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